Patient Testimonials Can't Go Beyond Efficacy Shown In Clinical Trials, FDA Says In Ad Letter For Lilly's Adcirca
This article was originally published in The Pink Sheet Daily
Executive Summary
The Division of Drug Marketing, Advertising and Communications finds the individual patient experience doesn't match up with the clinical trial results.
You may also be interested in...
Testimonials Lead To Overbroad Claims, DDMAC Warning Letter Says
Implied efficacy claims from a physician and patients for Testopel testosterone pellets, among many other problems with a series of promotional pieces, draw a warning letter to Slate Pharmaceuticals.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.